Project Details
| Short title | ERX-315-101 |
|---|---|
| Status | Active |
| Effective start/end date | 21/03/25 → 1/08/26 |
CTU: A First-in-Human, Phase 1 Safety, Tolerability, Pharmacokinetic and Preliminary Efficacy Study of Escalating Doses of ERX-315 in Participants with Advanced Solid Tumors
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Chik, Jenny (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
Project: Research